作者:
Veenstra,D.L. [1]
;
Piper,M. [2]
;
Haddow,J.E. [3]
;
Pauker,S.G. [4]
;
Klein,R. [5]
;
Richards,C.S. [6]
;
Tunis,S.R. [7]
;
Djulbegovic,B. [8]
;
Marrone,M. [9]
;
Lin,J.S. [10]
;
Berg,A.O. [11]
;
Calonge,N. [12]
作者单位:
Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, Institute for Public
[1]
Blue Cross and Blue Shield Association Technology Evaluation Center, Chicago, IL, United States
[2]
Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University
[3]
Division of Clinical Decision Making, Informatics and Telemedicine, Department of Medicine, Tufts
[4]
Blood Center of Wisconsin, H. Lee Moffitt Cancer Center, University of South Florida College of
[5]
Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
[6]
Center for Medical Technology Policy, Baltimore, MD, United States
[7]
Center for Evidence-Based Medicine and Health Outcomes, Department of Medicine, Departments of
[8]
Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GEO, United
[9]
Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States
[10]
Department of Family Medicine, University of Washington, Seattle, WA, United States
[11]
Colorado Trust, Denver, CO, United States
[12]
发布时间
2022-10-27